CD8A and COVID-19: In a retrospective analysis of immune profiles from 21 COVID-19 patients, Bobcakova et al. found significantly elevated levels of PD-1, but not TIM3, on CD4+ and CD8+ T cells in survivors compared to those who died from COVID-19.